FDA approves Cypress’ new cold medicines
by For the MBJ Published: June 14,2011
Tags: distribution, drugs, federal government, manufacturing, marketing, medicine, product introduction, product roll-out
MADISON — Cypress Pharmaceutical announced the Food and Drug Administration (FDA) has approved a new drug application (NDA) for Zutripro (hydrocodone bitartrate, chlorpheniramine maleate and pseudoephedrine HCl) Oral Solution (CIII) and Rezira (hydrocodone bitartrate and pseudoephedrine HCl) Oral Solution (CIII). Both products are indicated for the relief of cough and symptoms associated with the common [...] [...]
Loading ...